Trevor wins silver and bronze at the British Transplant Games
After a donor stem cell transplant, Trevor set his sights on the British Transplant Games
News
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
Informed patients have better outcomes
Stephen Scowcroft, our Business Development Manager summarises the Lymphoma Coalition Global Summit 2018 held in Prague in July 2018
Can you spare 15 minutes for a survey about clinical trials?
If you have used Lymphoma TrialsLink, your feedback could help us improve this information service
Pembrolizumab for classical Hodgkin lymphoma
NICE/NHS England recommend pembrolizumab for people with relapsed or refractory Hodgkin lymphoma who have had brentuximab vedotin and cannot have an autologous stem cell transplant
Have your say: how can cancer care be improved?
If you would like to share your views on how cancer care could be improved, Cancer52 would like to hear from you.
Ask the expert: Who attends an MDT meeting and can I have my views included?
Patients are not involved in MDT meetings as various other cases are discussed, so there is a problem of confidentiality. But talk to your CNS to see whether they could represent your views.
Would you like to learn more about new and future treatments?
Our Education and Training Manager, Helen Mee, talks about our upcoming event in Glasgow and explains why you should join us
New CLL guidelines published
The British Society of Haematology have published their guidelines on the treatment of chronic lymphocytic leukaemia
Which antibody to use first-line for follicular lymphoma?
Should obinutuzumab be used as part of the first-line treatment of follicular lymphoma or should we stick with rituximab?
Support for people on active monitoring for lymphoma
It can be difficult knowing you have an illness but are not having treatment - our new information can help.